Trial to Compare the Effects of Either Telmisartan (40-80 mg PO Once Daily) or Ramipril (5-10 mg PO Once Daily) on Renal Endothelial Dysfunction in Hypertensive Patients With Type 2 Diabetes

Name: Trial to Compare the Effects of Either Telmisartan (40-80 mg PO Once Daily) or Ramipril (5-10 mg PO Once Daily) on Renal Endothelial Dysfunction in Hypertensive Patients With Type 2 Diabetes
License: Public Domain

Boehringer Ingelheim

ClinicalTrials.gov · Datasets · License: Public Domain

Open Source ↗

diabetes-mellitus hypertension type-2

diabetes mellitus, type 2, hypertension

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 125983
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.